LAZARD INC (LAZ)

US52110M1099 - Common Stock

52.04  +1.55 (+3.07%)

After market: 52.04 0 (0%)

Fundamental Rating

4

Overall LAZ gets a fundamental rating of 4 out of 10. We evaluated LAZ against 220 industry peers in the Capital Markets industry. LAZ has an average financial health and profitability rating. LAZ has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year LAZ was profitable.
In the past year LAZ had a positive cash flow from operations.
Of the past 5 years LAZ 4 years were profitable.
Each year in the past 5 years LAZ had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.72%, LAZ is doing worse than 84.33% of the companies in the same industry.
Looking at the Return On Equity, with a value of -18.87%, LAZ is doing worse than 85.71% of the companies in the same industry.
LAZ has a Return On Invested Capital of 2.95%. This is in the lower half of the industry: LAZ underperforms 64.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LAZ is in line with the industry average of 7.00%.
The last Return On Invested Capital (2.95%) for LAZ is well below the 3 year average (7.39%), which needs to be investigated, but indicates that LAZ had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.72%
ROE -18.87%
ROIC 2.95%
ROA(3y)3.85%
ROA(5y)4.64%
ROE(3y)32.54%
ROE(5y)37.47%
ROIC(3y)7.39%
ROIC(5y)7.62%

1.3 Margins

With a Operating Margin value of 5.01%, LAZ is not doing good in the industry: 78.34% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of LAZ has declined.
The Gross Margin of LAZ (92.78%) is better than 91.71% of its industry peers.
LAZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.01%
PM (TTM) N/A
GM 92.78%
OM growth 3Y-35.81%
OM growth 5Y-26.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.1%
GM growth 5Y-0.13%

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, LAZ has more shares outstanding
LAZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LAZ has been reduced compared to a year ago.

2.2 Solvency

LAZ has an Altman-Z score of 1.95. This is not the best score and indicates that LAZ is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of LAZ (1.95) is better than 72.35% of its industry peers.
LAZ has a debt to FCF ratio of 16.32. This is a negative value and a sign of low solvency as LAZ would need 16.32 years to pay back of all of its debts.
With a Debt to FCF ratio value of 16.32, LAZ perfoms like the industry average, outperforming 49.31% of the companies in the same industry.
A Debt/Equity ratio of 5.25 is on the high side and indicates that LAZ has dependencies on debt financing.
LAZ has a worse Debt to Equity ratio (5.25) than 85.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.25
Debt/FCF 16.32
Altman-Z 1.95
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.14 indicates that LAZ should not have too much problems paying its short term obligations.
LAZ has a Current ratio (1.14) which is comparable to the rest of the industry.
LAZ has a Quick Ratio of 1.14. This is a normal value and indicates that LAZ is financially healthy and should not expect problems in meeting its short term obligations.
LAZ's Quick ratio of 1.14 is in line compared to the rest of the industry. LAZ outperforms 51.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 188.31% over the past year.
LAZ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -29.20% yearly.
The Revenue has decreased by -8.55% in the past year.
LAZ shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.97% yearly.
EPS 1Y (TTM)188.31%
EPS 3Y-40.87%
EPS 5Y-29.2%
EPS Q2Q%280%
Revenue 1Y (TTM)-8.55%
Revenue growth 3Y-0.45%
Revenue growth 5Y-1.97%
Sales Q2Q%21.5%

3.2 Future

LAZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.65% yearly.
Based on estimates for the next years, LAZ will show a quite strong growth in Revenue. The Revenue will grow by 14.72% on average per year.
EPS Next Y204.53%
EPS Next 2Y135.39%
EPS Next 3Y88.9%
EPS Next 5Y71.65%
Revenue Next Year22.31%
Revenue Next 2Y18.05%
Revenue Next 3Y14.72%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.44, the valuation of LAZ can be described as rather expensive.
LAZ's Price/Earnings ratio is a bit more expensive when compared to the industry. LAZ is more expensive than 64.52% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. LAZ is around the same levels.
Based on the Price/Forward Earnings ratio of 12.69, the valuation of LAZ can be described as correct.
LAZ's Price/Forward Earnings ratio is in line with the industry average.
LAZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 23.44
Fwd PE 12.69

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LAZ is on the same level as its industry peers.
LAZ's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.04
EV/EBITDA 36.08

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LAZ's earnings are expected to grow with 88.90% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y135.39%
EPS Next 3Y88.9%

5

5. Dividend

5.1 Amount

LAZ has a Yearly Dividend Yield of 3.96%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 9.45, LAZ has a dividend in line with its industry peers.
LAZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.96%

5.2 History

The dividend of LAZ decreases each year by -6.19%.
LAZ has been paying a dividend for at least 10 years, so it has a reliable track record.
LAZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-6.19%
Div Incr Years2
Div Non Decr Years11

5.3 Sustainability

LAZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-216.46%
EPS Next 2Y135.39%
EPS Next 3Y88.9%

LAZARD INC

NYSE:LAZ (12/20/2024, 8:21:47 PM)

After market: 52.04 0 (0%)

52.04

+1.55 (+3.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)01-30 2025-01-30/bmo
Inst Owners69.13%
Inst Owner Change3.46%
Ins Owners0.85%
Ins Owner Change-12.16%
Market Cap5.87B
Analysts77.14
Price Target60.05 (15.39%)
Short Float %3%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield 3.96%
Dividend Growth(5Y)-6.19%
DP-216.46%
Div Incr Years2
Div Non Decr Years11
Ex-Date11-08 2024-11-08 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.09%
Min EPS beat(2)-38.38%
Max EPS beat(2)60.56%
EPS beat(4)2
Avg EPS beat(4)-11.92%
Min EPS beat(4)-200.56%
Max EPS beat(4)130.7%
EPS beat(8)5
Avg EPS beat(8)-1.2%
EPS beat(12)8
Avg EPS beat(12)5.42%
EPS beat(16)11
Avg EPS beat(16)14.38%
Revenue beat(2)1
Avg Revenue beat(2)1.29%
Min Revenue beat(2)-8.67%
Max Revenue beat(2)11.26%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)11.26%
Revenue beat(8)5
Avg Revenue beat(8)3.63%
Revenue beat(12)9
Avg Revenue beat(12)6.4%
Revenue beat(16)12
Avg Revenue beat(16)8.44%
PT rev (1m)9.28%
PT rev (3m)14.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 23.44
Fwd PE 12.69
P/S 2.25
P/FCF 43.04
P/OCF 35.64
P/B 13.85
P/tB 203.55
EV/EBITDA 36.08
EPS(TTM)2.22
EY4.27%
EPS(NY)4.1
Fwd EY7.88%
FCF(TTM)1.21
FCFY2.32%
OCF(TTM)1.46
OCFY2.81%
SpS23.15
BVpS3.76
TBVpS0.26
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.72%
ROE -18.87%
ROCE 4.48%
ROIC 2.95%
ROICexc 4.56%
ROICexgc 7.26%
OM 5.01%
PM (TTM) N/A
GM 92.78%
FCFM 5.22%
ROA(3y)3.85%
ROA(5y)4.64%
ROE(3y)32.54%
ROE(5y)37.47%
ROIC(3y)7.39%
ROIC(5y)7.62%
ROICexc(3y)14.15%
ROICexc(5y)15.91%
ROICexgc(3y)17.62%
ROICexgc(5y)20.39%
ROCE(3y)12.62%
ROCE(5y)13.44%
ROICexcg growth 3Y-36.23%
ROICexcg growth 5Y-27.1%
ROICexc growth 3Y-36.72%
ROICexc growth 5Y-27.6%
OM growth 3Y-35.81%
OM growth 5Y-26.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.1%
GM growth 5Y-0.13%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 5.25
Debt/FCF 16.32
Debt/EBITDA 12.79
Cap/Depr 65.52%
Cap/Sales 1.08%
Interest Coverage 1.78
Cash Conversion 94.59%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 1.95
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)95.22%
Cap/Depr(5y)116.03%
Cap/Sales(3y)1.34%
Cap/Sales(5y)1.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)188.31%
EPS 3Y-40.87%
EPS 5Y-29.2%
EPS Q2Q%280%
EPS Next Y204.53%
EPS Next 2Y135.39%
EPS Next 3Y88.9%
EPS Next 5Y71.65%
Revenue 1Y (TTM)-8.55%
Revenue growth 3Y-0.45%
Revenue growth 5Y-1.97%
Sales Q2Q%21.5%
Revenue Next Year22.31%
Revenue Next 2Y18.05%
Revenue Next 3Y14.72%
Revenue Next 5YN/A
EBIT growth 1Y-74.67%
EBIT growth 3Y-36.1%
EBIT growth 5Y-27.67%
EBIT Next Year213.95%
EBIT Next 3Y85.65%
EBIT Next 5Y47.86%
FCF growth 1Y-82.62%
FCF growth 3Y-35.64%
FCF growth 5Y-26.81%
OCF growth 1Y-80.26%
OCF growth 3Y-34.12%
OCF growth 5Y-25.11%